Earnings growth forecast for next year: VistaGen Therapeutics Inc (VTGN)

Public company logo of Vistagen Therapeutics (VTGN)

Management transparency at Vistagen Therapeutics (VTGN) in its reports minimizes investor risks. Forward earnings per share dynamics visualize these expectations, where 0.00 indicates the current level. Vistagen Therapeutics relies on a staff of leading neurobiologists whose loyalty is secured through stock options. High barriers to entry are created by patents for nasal drug delivery, protecting the business from new entrants in the psychiatry sector.

Vistagen Therapeutics (VTGN): Projected earnings per share growth rate for next year from 07/04/2022 to 11/18/2026

Financial and market metric breakdowns for VistaGen Therapeutics, Inc. (VTGN)

- share price and consensus valuation forecast:
- company stock exchange capitalization indicators:
Fundamental company valuation:Vistagen Therapeutics, VTGN
Brand item of Vistagen

The development dynamics of the Vistagen Therapeutics (VTGN) nasal spray pipeline are reflected in the expected growth of earnings per share. This metric aggregates analyst forecasts for future profitability, separating actual market demand from corporate management statements. Comparing these expectations with clinical trial phases allows investors to assess the fundamental stability of the business and the risk of asset overheating prior to the product's market launch.

Competitors of Vistagen Therapeutics

Net earnings per share growth forecast for next year Biogen|Expected earnings per share growth for next year neurocrine.com (NBIX)|Net earnings per share growth forecast for next year Regencell Bioscience Holdings Limited (RGC)|AXSM (Axsome Therapeutics Inc) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year ACADIA Pharmaceuticals Inc. ACAD|Expected earnings per share trend next year XENE|Viking Therapeutics - Earnings growth forecast for next year|Expected earnings per share trend next year SUPN (supernus.com)|Catalyst Pharmaceuticals (CPRX) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Denali (DNLI)|Net earnings per share growth forecast for next year harmonybiosciences.com|BHVN (Biohaven Pharmaceutical) - Projected earnings per share increase next year|Net earnings per share growth forecast for next year amylyx.com (AMLX)|TRVI: Net earnings per share change forecast for next year|Net earnings per share growth forecast for next year Praxis Precision Medicines Inc PRAX|Consensus forecast of earnings per share growth for next year Anavex Life Sciences Corp. (AVXL)|CeriBell EEG - Earnings growth forecast for next year|Expected net earnings per share growth next year Prothena Corp|ALEC: Earnings growth forecast for next year|Projected earnings per share growth rate for next year ANNX|OMER (Omeros) - Earnings growth forecast for next year|NGNE - Net earnings per one share growth forecast for next year|Net earnings per share growth forecast for next year AC Immune Corp (ACIU)|Projected earnings per share increase next year VYGR|Earnings growth forecast for next year NMRA (neumoratx.com)|SCLX - Expected earnings per share growth for next year|tevogen.com - Earnings growth forecast for next year|Net earnings per one share growth forecast for next year Alpha Cognition Inc. (ACOG)|CGTX: Earnings growth forecast for next year|IKT - Consensus forecast of earnings per share growth for next year|Expected earnings per share growth for next year SAVA|Expected earnings per share growth for next year Assertio (ASRT)|Expected earnings per share growth for next year COYA (Coya)|Consensus forecast of earnings per share growth for next year Ovid Therapeutics Inc|Earnings growth forecast for next year ABOS (Acumen Pharmaceuticals Inc.)|CRVO - Expected earnings per share growth for next year|Alterity Therapeutics Limited - Earnings growth forecast for next year|Expected net earnings per share growth next year Clene Inc|PEPG: Earnings growth forecast for next year|Expected earnings per share growth for next year jupiterneurosciences.com|RLMD (relmada.com) - Earnings growth forecast for next year|Earnings growth forecast for next year Annovis Bio Corporation|Earnings growth forecast for next year GRCE|AIFF: Net earnings per share change forecast for next year|Net earnings per share growth forecast for next year Klotho Neurosciences KLTO|NRSN: Projected earnings per share growth rate for next year|RVPH: Expected earnings per share growth for next year|Consensus forecast of earnings per share growth for next year MetaVia MTVA|neuraxis.com (NRXS) - Net earnings per share growth forecast for next year|Helius Medical Technologies Inc. - Expected earnings per share trend next year|PASG (Passage Bio, Inc.) - Earnings growth forecast for next year|bionomics.com.au - Net earnings per share change forecast for next year|Earnings growth forecast for next year NERV|ATHA (Athira) - Expected earnings per share trend next year|Addex Therapeutics - Expected earnings per share growth for next year|ALZN - Expected earnings per share growth for next year|Cyclerion Therapeutics, Inc. - Earnings growth forecast for next year|Expected earnings per share trend next year PTIX (Protagenic Therapeutics, Inc.)|KTTA (pasitheaclinics.com) - Expected earnings per share growth for next year|Projected earnings per share growth rate for next year CRGT|Expected earnings per share growth for next year ATXI|Expected earnings per share growth for next year Brainstorm Cell (BCLI)|Expected earnings per share growth for next year CARA (Cara Therapeutics, Inc.)|Expected earnings per share growth for next year Chromocell Therapeutics Corp CHRO|Earnings growth forecast for next year ELYM (Eliem Therapeutics, Inc.)|Earnings growth forecast for next year intracellulartherapies.com ITCI|Longboard Pharmaceuticals - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year Marinus Pharmaceuticals, Inc. MRNS|NKGN: Earnings growth forecast for next year|NeuroBo Pharmaceuticals Inc - Expected earnings per share trend next year|SAGE (Sage Therapeutics Inc.) - Earnings growth forecast for next year|Projected earnings per share growth rate for next year SNPX (Neurotrope)|Net earnings per share growth forecast for next year Trevena Inc. (TRVN)|VIGL - Expected net earnings per share growth next year|Anew Medical Inc. - Expected earnings per share growth for next year|CERE (Cerevel Therapeutics, Inc.) - Net earnings per share change forecast for next year